We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Abraham Morgentaler

Abraham Morgentaler MD, FACS

Director and Founder, Men's Health Boston, Associate Clinical Professor of Urology, Harvard Medical School, Cambridge, Massachusetts

Recent Contributions to PracticeUpdate:

  1. Incidence of AF Sinks Following Normalization of Testosterone Levels After Testosterone Replacement Therapy
  2. Long-Term Testosterone and Risk of High-Grade Prostate Cancer
  3. Testosterone Replacement Therapy for PCa Does Not Increase Mortality

Most Read This Week

Recently Updated